围术期使用艾司氯胺酮在加速康复外科的应用进展
Application Progress of Esketamine in Enhanced Recovery after Surgery during Perioperative Period
DOI: 10.12677/ACM.2023.1371654, PDF,    科研立项经费支持
作者: 杨丽娇：大理大学临床学院，麻醉科，云南 大理；张茂荷*：大理大学第一附属医院，麻醉科，云南 大理
关键词: 艾司氯胺酮；加速康复外科；多模式镇痛；Esketamine； Enhanced Recovery after Surgery； Multimodal Analgesia
摘要: 随着加速康复外科理念的不断推广和普及，围术期的操作均有目的的遵循如何加速康复。而疼痛是临床常见影响康复的并发症之一，疼痛不仅能刺激交感神经，引发一系列应激反应，还能影响神经内分泌功能，导致术后精神心理状态改变和内环境紊乱，是影响患者康复的重要因素。多模式镇痛和减少术后并发症越来越被重视。围术期使用艾司氯胺酮是多模式镇痛的重要策略之一，可以明显减少阿片类药物用量，有效提高术后镇痛满意率，预防并减轻术后并发症，加速患者康复。本文基于加速康复外科理念，对艾司氯胺酮药理学特点、临床疗效以及在围术期的临床应用进展进行综述。
Abstract: With the developing popularization of the concept of enhanced recovery after surgery (ERAS), perioperative procedures pay attention to accelerating rehabilitation. It is pain that is one of the common complications which affects rehabilitation in clinical practice. Not only can the sympathetic nervous system be stimulated and a series of stress reactions be led, but also the neuroendocrine function can be influenced, which will bring some changes in mental and psychological status and internal environment disorder after surgery, therefore pain is an important factor affecting the re-habilitation of patients. Multi-mode analgesia and reducing postoperative complications are in-creasingly being valued. Using esketamine during the perioperative period is one of the important strategies for multimodal analgesia, which can significantly reduce the usage of opioids, effectively improve the satisfaction rate of postoperative analgesia, prevent and reduce postoperative compli-cations, and accelerate the recovery of patients. Based on the concept of accelerated rehabilitation surgery, this article reviews the pharmacological characteristics, clinical efficacy, and clinical appli-cation progress of ketamine in perioperative period.
文章引用：杨丽娇, 张茂荷. 围术期使用艾司氯胺酮在加速康复外科的应用进展[J]. 临床医学进展, 2023, 13(7): 11804-11812. https://doi.org/10.12677/ACM.2023.1371654

参考文献

[1] 中国加速康复外科临床实践指南(2021) (一) [J]. 协和医学杂志, 2021, 12(5): 624-631.
[2] Persson, J. (2010) Wherefore Ketamine? Current Opinion in Anesthesiology, 23, 455-460. [Google Scholar] [CrossRef] 
[3] Ihmsen, H., Geisslinger, G. and Schüttler, J. (2001) Stere-oselective Pharmacokinetics of Ketamine: R(−)-Ketamine Inhibits the Elimination of S(+)-Ketamine. Clinical Pharma-cology & Therapeutics, 70, 431-438. [Google Scholar] [CrossRef] [PubMed]
[4] Henthorn, T.K., Avram, M.J., Dahan, A., et al. (2018) Combined Recirculatory-Compartmental Population Pharmacokinetic Modeling of Arterial and Venous Plasma S(+) and R(−) Ket-amine Concentrations. Anesthesiology, 129, 260-270. [Google Scholar] [CrossRef] 
[5] Sleigh, J., Harvey, M., Voss, L., et al. (2014) Ketamine—More Mechanisms of Action than Just NMDA Blockade. Trends in Anaesthesia and Critical Care, 4, 76-81. [Google Scholar] [CrossRef] 
[6] Schatzberg, A.F. (2014) A Word to the Wise about Ketamine. American Journal of Psychiatry, 171, 262-264. [Google Scholar] [CrossRef] [PubMed]
[7] 白冰, 田园, 张越伦, 等. 超声引导下平面外法桡动脉成功置管和并发症的相关因素[J]. 中国医学科学院学报, 2020, 42(1): 86-90.
[8] Kamp, J., Jonkman, K., van Velzen, M., et al. (2020) Pharmacokinetics of Ketamine and Its Major Metabolites Norketamine, Hydroxynorketamine, and De-hydronorketamine: A Model-Based Analysis. British Journal of Anaesthesia, 125, 750-761. [Google Scholar] [CrossRef] [PubMed]
[9] Bolshakov, K.V., Gmiro, V.E., Tikhonov, D.B., et al. (2003) De-terminants of Trapping Block of N-methyl-d-aspartate Receptor Channels. Journal of Neurochemistry, 87, 56-65. [Google Scholar] [CrossRef] [PubMed]
[10] Lanthorn, T.H., Mealing, G.A.R. and Morley, P. (2000) Differences in Degree of Trapping between AR-R15896 and Other Uncompetitive NMDA Receptor Antagonists. Amino Acids, 19, 173-175. [Google Scholar] [CrossRef] [PubMed]
[11] Li, L. and Vlisides, P.E. (2016) Ketamine: 50 Years of Modulating the Mind. Frontiers in Human Neuroscience, 10, Article No. 612. [Google Scholar] [CrossRef] [PubMed]
[12] Ohnesorge, H., Feng, Z., Zitta, K., et al. (2013) Influence of Clonidine and Ketamine on m-RNA Expression in a Model of Opioid-Induced Hyperalgesia in Mice. PLOS ONE, 8, e79567. [Google Scholar] [CrossRef] [PubMed]
[13] Hayashi, Y., Kawaji, K., Sun, L., et al. (2011) Micro-glial Ca(2+)-Activated K(+) Channels Are Possible Molecular Targets for the Analgesic Effects of S-Ketamine on Neu-ropathic Pain. Journal of Neuroscience, 31, 17370-17382. [Google Scholar] [CrossRef] 
[14] Mei, X., Wang, W., Wang, W., et al. (2009) Inhibiting Astrocytic Activation: A Novel Analgesic Mechanism of Ketamine at the Spinal Level? Journal of Neurochemistry, 109, 1691-1700. [Google Scholar] [CrossRef] [PubMed]
[15] Blednov, Y.A., Stoffel, M., Alva, H., et al. (2003) A Per-vasive Mechanism for Analgesia: Activation of GIRK2 Channels. Proceedings of the National Academy of Sciences, 100, 277-282. [Google Scholar] [CrossRef] [PubMed]
[16] 杜宁, 李娴, 樊碧发, 等. MAPK和NO相关信号通路在电针镇痛作用机理的研究进展[J]. 中国疼痛医学杂志, 2019, 25(11): 854-858.
[17] Liu, Y., Zheng, Y., Gu, X., et al. (2012) The Efficacy of NMDA Receptor Antagonists for Preventing Remifentanil-Induced Increase in Postoperative Pain and Analgesic Requirement: A Meta-Analysis. Minerva Anestesiologica, 78, 653-667.
[18] Laskowski, K., Stirling, A., Mckay, W.P., et al. (2011) A Systematic Review of Intravenous Ketamine for Postoperative Analgesia. Canadian Journal of Anesthesia, 58, 911-923. [Google Scholar] [CrossRef] [PubMed]
[19] Petrenko, A.B., Yamakura, T., Kohno, T., et al. (2013) Increased Brain Monoaminergic Tone after the NMDA Receptor GluN2A Subunit Gene Knockout Is Responsible for Resistance to the Hypnotic Effect of Nitrous Oxide. European Journal of Pharmacology, 698, 200-205. [Google Scholar] [CrossRef] [PubMed]
[20] Zhou, C., Douglas, J.E., Kumar, N.N., et al. (2013) Forebrain HCN1 Channels Contribute to Hypnotic Actions of Ketamine. Anesthesiology, 118, 785-795. [Google Scholar] [CrossRef] 
[21] Mazzeffi, M., Johnson, K. and Paciullo, C. (2015) Ketamine in Adult Cardiac Surgery and the Cardiac Surgery Intensive Care Unit: An Evidence-Based Clinical Review. Annals of Cardiac Anaesthesia, 18, 202-209. [Google Scholar] [CrossRef] [PubMed]
[22] 高长胜, 黄符香, 李永乐. 艾司氯胺酮静注在人工流产术中的应用效果观察[J]. 山东医药, 2022, 62(11): 56-58.
[23] Jonkman, K., Van Rijnsoever, E., Olofsen, E., et al. (2018) Esketamine Counters Opioid-Induced Respiratory Depression. British Journal of Anaesthesia, 120, 1117-1127. [Google Scholar] [CrossRef] [PubMed]
[24] 王秀红. 亚麻醉剂量艾司氯胺酮调控小胶质细胞TLR4/NF-κB通路对术后认知影响及机制研究[D]: [博士学位论文]. 南昌: 南昌大学, 2021.
[25] Niu, X., Zheng, S., Li, S., et al. (2023) Role of Different Doses of Ketamine in Postoperative Neurocognitive Function in Aged Mice Undergoing Partial Hepatectomy by Regulating the Bmal1/NMDA/NF-κB Axis. European Surgical Research, 63, 182-195. [Google Scholar] [CrossRef] [PubMed]
[26] Mercadante, S., Arcuri, E. and Santoni, A. (2019) Opioid-Induced Toler-ance and Hyperalgesia. CNS Drugs, 33, 943-955. [Google Scholar] [CrossRef] [PubMed]
[27] Guo, W., Wei, F., Zou, S., et al. (2004) Group I Metabotropic Glutamate Receptor NMDA Receptor Coupling and Signaling Cascade Mediate Spinal Dorsal Horn NMDA Receptor 2B Tyrosine Phosphorylation Associated with Inflammatory Hyperalgesia. Journal of Neuroscience, 24, 9161-9173. [Google Scholar] [CrossRef] 
[28] Gardell, L.R., Wang, R., Burgess, S.E., et al. (2002) Sustained Morphine Exposure Induces a Spinal Dynorphin-Dependent Enhancement of Excitatory Transmitter Release from Primary Afferent Fibers. Journal of Neuroscience, 22, 6747-6755. [Google Scholar] [CrossRef] 
[29] Borgland, S.L. (2001) Acute Opioid Receptor De-sensitization and Tolerance: Is There a Link? Clinical and Experimental Pharmacology and Physiology, 28, 147-154. [Google Scholar] [CrossRef] [PubMed]
[30] Zhao, Y.L., Chen, S.R., Chen, H., et al. (2012) Chronic Opioid Potentiates Presynaptic but Impairs Postsynaptic N-methyl-D-aspartic Acid Receptor Activity in Spinal Cords: Implications for Opioid Hyperalgesia and Tolerance. Journal of Biological Chemistry, 287, 25073-25085. [Google Scholar] [CrossRef] 
[31] Joly, V., Richebe, P., Guignard, B., et al. (2005) Remifentan-il-Induced Postoperative Hyperalgesia and Its Prevention with Small-Dose Ketamine. The Journal of the American Soci-ety of Anesthesiologists, 103, 147-155. [Google Scholar] [CrossRef] [PubMed]
[32] Koppert, W., Sittl, R., Scheuber, K., et al. (2003) Dif-ferential Modulation of Remifentanil-Induced Analgesia and Postinfusion Hyperalgesia by S-Ketamine and Clonidine in Humans. The Journal of the American Society of Anesthesiologists, 99, 152-159. [Google Scholar] [CrossRef] [PubMed]
[33] 徐莉莉, 靳彦涛, 杨征, 等. 右美托咪定联合小剂量氯胺酮对老年冠心病非心脏手术患者围手术期的效果及对自主神经系统功能的影响[J]. 河北医药, 2020, 42(13): 1971-1973.
[34] Cavalleri, L., Merlo Pich, E., Millan, M.J., et al. (2018) Ketamine Enhances Structural Plasticity in Mouse Mesencephalic and Human iPSC-Derived Dopaminergic Neurons via AMPAR-Driven BDNF and mTOR Sig-naling. Molecular Psychiatry, 23, 812-823. [Google Scholar] [CrossRef] [PubMed]
[35] Chang, L., Zhang, K., Pu, Y., et al. (2019) Comparison of Antidepressant and Side Effects in Mice after Intranasal Administration of (R,S)-Ketamine, (R)-Ketamine, and (S)-Ketamine. Pharmacology Biochemistry and Behavior, 181, 53-59. [Google Scholar] [CrossRef] [PubMed]
[36] Hirota, K., Sato, T., Rabito, S.F., et al. (1996) Relaxant Effect of Ketamine and Its Isomers on Histamine-Induced Contraction of Tracheal Smooth Muscle. British Journal of Anaesthesia, 76, 266-270. [Google Scholar] [CrossRef] [PubMed]
[37] 朱敏敏, 钱燕宁, 朱伟, 等. 氯胺酮对致敏原诱导哮喘模型大鼠的肺保护[J]. 中华医学杂志, 2007, 87(19): 1308-1313.
[38] Chungsamarnyart, Y., Pairart, J. and Munjupong, S. (2022) Comparison of the Effects of Intravenous Propofol and Propofol with Low-Dose Ketamine on Preventing Postextubation Cough and Laryngospasm among Patients Awakening from General Anaesthesia: A Prospective Randomised Clinical Trial. Journal of Perioperative Practice, 32, 53-58. [Google Scholar] [CrossRef] [PubMed]
[39] Tobias, J.D. (2018) Preoperative Anesthesia Evaluation. Seminars in Pediatric Surgery, 27, 67-74. [Google Scholar] [CrossRef] [PubMed]
[40] Dreger, V.A. and Tremback, T.F. (2006) Management of Preoperative Anxiety in Children. AORN Journal, 84, 777-804. [Google Scholar] [CrossRef] 
[41] 孙东燕, 姜雪丽, 刘清兰, 等. 艾司氯胺酮复合右美托咪定/咪达唑仑术前镇静治疗的临床观察[J]. 大理大学学报, 2022, 7(8): 66-70.
[42] Johansson, J., Sjöberg, J., Nordgren, M., et al. (2013) Prehospital Analgesia Using Nasal Administration of S-Ketamine— A Case Series. Scandi-navian Journal of Trauma, Resuscitation and Emergency Medicine, 21, Article No. 38. [Google Scholar] [CrossRef] [PubMed]
[43] Rugg, C., Woyke, S., Ausserer, J., et al. (2021) Analgesia in Pediat-ric Trauma Patients in Physician-Staffed Austrian Helicopter Rescue: A 12-Year Registry Analysis. Scandinavian Jour-nal of Trauma, Resuscitation and Emergency Medicine, 29, Article No. 161. [Google Scholar] [CrossRef] [PubMed]
[44] Nemeth, M., Jacobsen, N., Bantel, C., et al. (2019) Intranasal Analgesia and Sedation in Pediatric Emergency Care—A Prospective Observational Study on the Implementation of an Institutional Protocol in a Tertiary Children’s Hospital. Pediatric Emergency Care, 35, 89-95. [Google Scholar] [CrossRef] 
[45] Miziara, L.E.P.G., Simoni, R.F., Esteves, L.O., et al. (2016) Efficacy of Continuous S(+)-Ketamine Infusion for Postoperative Pain Control: A Randomized Placebo-Controlled Trial. Anesthesiology Research and Practice, 2016, Article ID: 6918327. [Google Scholar] [CrossRef] [PubMed]
[46] 陈家华, 陈锦莹, 关宇健. 亚剂量艾司氯胺酮复合右美托咪定对体外循环心脏瓣膜手术患者苏醒质量、术后认知功能、炎性指标的影响[J]. 吉林医学, 2022, 43(1): 144-146.
[47] 辛志军, 王宁, 曲伟栋, 等. 小剂量艾司氯胺酮在全身麻醉下口腔颌面外科短时间手术中的应用[J]. 口腔医学研究, 2023, 39(1): 46-51.
[48] Aronsohn, J., Orner, G., Palleschi, G., et al. (2018) Opioid-Free Total Intravenous Anesthesia with Ketamine as Part of an Enhanced Recovery Protocol for Bariatric Surgery Patients with Sleep Disordered Breathing. Journal of Clinical Anesthesia, 52, 65-66. [Google Scholar] [CrossRef] [PubMed]
[49] 叶春芳, 汪毅. 小剂量艾司氯胺酮预先给药对罗库溴铵缩肢反应的影响[J]. 安徽医学, 2021, 42(12): 1398-1400.
[50] Edinoff, A.N., Fitz-Gerald, J.S., Holland, K.A.A., et al. (2021) Adjuvant Drugs for Peripheral Nerve Blocks: The Role of NMDA Antagonists, Neostigmine, Epinephrine, and Sodium Bicarbonate. Anesthesiology and Pain Medicine, 11, e117146. [Google Scholar] [CrossRef] [PubMed]
[51] 顾晓霞, 庞萍, 彭雪, 等. 艾司氯胺酮预处理在臂丛神经阻滞老年手术患者的应用[J]. 江苏医药, 2021, 47(4): 356-358.
[52] Feltracco, P., Barbieri, S., Rizzi, S., et al. (2013) Perioperative Analgesic Efficacy and Plasma Concentra-tions of S(+)-Ketamine in Continuous Epidural Infusion during Thoracic Surgery. Anesthesia & Analgesia, 116, 1371-1375. [Google Scholar] [CrossRef] 
[53] Togal, T., Demirbilek, S., Koroglu, A., et al. (2004) Effects of S(+) Ketamine Added to Bupivacaine for Spinal Anaesthesia for Prostate Surgery in Elderly Patients. European Jour-nal of Anaesthesiology, 21, 193-197. [Google Scholar] [CrossRef] 
[54] Wang, W., Ling, B., Chen, Q., et al. (2023) Effect of Pre-Administration of Esketamine Intraoperatively on Postpartum Depression after Cesarean Section: A Randomized, Double-Blinded Controlled Trial. Medicine, 102, e33086. [Google Scholar] [CrossRef] 
[55] 徐帆, 甘建辉, 史金麟, 等. 亚麻醉剂量艾司氯胺酮联合瑞马唑仑在宫颈锥切术患者中的应用研究[J]. 实用医院临床杂志, 2022, 19(6): 63-66.
[56] Eberl, S., Koers, L., van Hooft, J., et al. (2020) The Effectiveness of a Low-Dose Esketamine versus an Alfentanil Adjunct to Propofol Seda-tion during Endoscopic Retrograde Cholangiopancreatography: A Randomised Controlled Multicentre Trial. European Journal of Anaesthesiology, 37, 394-401. [Google Scholar] [CrossRef] 
[57] 毛海飞, 梅楷波, 汪启明, 等. 艾司氯胺酮联合芬太尼在创伤性截肢术后幻肢痛患者中的应用效果[J]. 中国当代医药, 2022, 29(23): 119-121.
[58] 周斌, 邱珍, 孟庆涛, 等. 右美托咪定联合艾司氯胺酮用于老年患者乳腺癌根治术的术后镇痛[J/OL]. 中国新药与临床杂志: 1-6. http://kns.cnki.net/kcms/detail/31.1746.R.20221229.1600.003.html, 2023-06-10.

为你推荐